{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T01:50:56Z","timestamp":1649209856986},"reference-count":175,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1053\/j.semdp.2013.06.008","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T20:45:37Z","timestamp":1382129137000},"page":"245-262","source":"Crossref","is-referenced-by-count":1,"title":["Pathology, pathophysiology, and treatment strategies of endocrine disorders and their cardiac complications"],"prefix":"10.1053","volume":"30","author":[{"given":"Adriana","family":"Luk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish","family":"Butany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2013.06.008_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/er.23.1.38","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocrine Rev"},{"key":"10.1053\/j.semdp.2013.06.008_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","article-title":"Mortality after the treatment of hyperthyroidism with radioactive iodine","volume":"38","author":"Franklyn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.294.1.71","article-title":"Thyroid function and mortality in patients treated for hyperthyroidism","volume":"294","author":"Franklyn","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semdp.2013.06.008_bib5","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1210\/en.137.10.4235","article-title":"Uptake of thyroid hormones in neonatal rat cardiac myocytes","volume":"137","author":"Everts","year":"1996","journal-title":"Endocrinology"},{"key":"10.1053\/j.semdp.2013.06.008_bib6","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0601600103","article-title":"Rapid nongenomic actions of thyroid hormone","volume":"103","author":"Hiroi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2013.06.008_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.yjmcc.2005.07.019","article-title":"Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes","volume":"39","author":"Kuzman","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib8","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/en.136.4.1544","article-title":"Hormonal regulation of rat adrenomedullin gene in vasculature","volume":"136","author":"Imai","year":"1995","journal-title":"Endocrinology"},{"key":"10.1053\/j.semdp.2013.06.008_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/eje.0.1440339","article-title":"Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients","volume":"144","author":"Diekman","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semdp.2013.06.008_bib10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib11","first-page":"139","article-title":"Thyroid hormone and the cardiovascular system","volume":"29","author":"Danzi","year":"2004","journal-title":"Minerva Endocrinol"},{"key":"10.1053\/j.semdp.2013.06.008_bib12","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-030039","article-title":"Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy","volume":"88","author":"Taddei","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejim.2005.11.023","article-title":"Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy","volume":"17","author":"Marvisi","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000441-199911000-00001","article-title":"High prevalence of hypothyroidism in patients with primary pulmonary hypertension","volume":"318","author":"Curnock","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.semdp.2013.06.008_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/105072502760143809","article-title":"Cellular action of thyroid hormone on the heart","volume":"12","author":"Dillmann","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.semdp.2013.06.008_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.75.2.245","article-title":"Thyroid hormone-induced alterations in phospholamban protein expression: regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation","volume":"75","author":"Kiss","year":"1994","journal-title":"Circ Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.CIR.96.2.592","article-title":"Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons","volume":"96","author":"Hoit","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib18","first-page":"E302","article-title":"Thyroid hormone induces beta1-adrenegic receptor gene transcription through a direct repeat separated by five nucleotides","volume":"278","author":"Bahouth","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0026-0495(00)92262-5","article-title":"Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness","volume":"49","author":"Ojamaa","year":"2000","journal-title":"Metabolism"},{"key":"10.1053\/j.semdp.2013.06.008_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01868642","article-title":"Thryoidal enhancement of rat myocardial Na, K-ATPase: preferential expression of alpha 2 activity and mRNA abundance","volume":"115","author":"Gick","year":"1990","journal-title":"J Membr Biol"},{"key":"10.1053\/j.semdp.2013.06.008_bib22","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/en.140.7.3170","article-title":"Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rabid and chamber specific","volume":"140","author":"Ojamaa","year":"1999","journal-title":"Endocrinology"},{"key":"10.1053\/j.semdp.2013.06.008_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-5223(94)70292-6","article-title":"The novel effects of 3,5,3\u2032 triiodo-l-thyronine on myocyte contractile function and beta adrenergic responsiveness in dilated cardiomyopathy","volume":"108","author":"Walker","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semdp.2013.06.008_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/01.CIR.87.5.1451","article-title":"Regulation of myosin heavy chain genes in the heart","volume":"87","author":"Morkin","year":"1993","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/en.137.3.802","article-title":"Thyroid hormone and hemodynamic regulation of beta-myosin chain promotor in the heart","volume":"137","author":"Ojamaa","year":"1996","journal-title":"Endocrinology"},{"key":"10.1053\/j.semdp.2013.06.008_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.semdp.2013.06.008_bib27","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.87.4.1533","article-title":"Lipoprotein profile in subclinical hypothyroidism: response to replacement, a randomized placebo-controlled study","volume":"87","author":"Caraccio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib28","first-page":"574","article-title":"Role of thyroid disease in the development of statin-induced myopathy","volume":"145","author":"Rush","year":"2006","journal-title":"Endocrinologist"},{"key":"10.1053\/j.semdp.2013.06.008_bib29","first-page":"2104","article-title":"Disorders of the thyroid gland","volume":"Volume II","author":"Jameson","year":"2005"},{"key":"10.1053\/j.semdp.2013.06.008_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hyperthyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00019501-200505000-00001","article-title":"Severe coronary artery spasm can be associated with hyperthyroidism","volume":"16","author":"Choi","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1053\/j.semdp.2013.06.008_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.0954-6820.1983.tb03724.x","article-title":"Long QT interval and ventricular tachycardia of \u201ctorsade de pointe\u201d type in hypothyroidism","volume":"213","author":"Fredlund","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1053\/j.semdp.2013.06.008_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00000441-200603000-00008","article-title":"Severe Primary Hypothyroidism manifesting with torsade de pointes","volume":"331","author":"Schenck","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.semdp.2013.06.008_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0021-9150(02)00372-6","article-title":"Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothryoidism? A cross-sectional and a double blind palcebo-controlled trial","volume":"166","author":"Christ-Crain","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.semdp.2013.06.008_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-121-4-199408150-00010","article-title":"Treatment of hyperthyroid disease","volume":"121","author":"Klein","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","article-title":"Management of atrial fibrillation in the post-thyrotoxic state","volume":"72","author":"Nakazawa","year":"1982","journal-title":"Am J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib38","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI111561","article-title":"Effects of thyroid hormone on sodium pump sites, sodium content and contractile responses to cardiac glycosides in cultured chick venticular cells","volume":"74","author":"Kim","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib39","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/archinte.1988.00380090021007","article-title":"The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients","volume":"148","author":"Roti","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11906-003-0060-7","article-title":"Thryoid hormone and blood pressure regulation","volume":"5","author":"Danzi","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1053\/j.semdp.2013.06.008_bib41","first-page":"712","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older patients","volume":"38","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotopin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semdp.2013.06.008_bib44","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2006-1869","article-title":"The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism:randomized, crossover trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib45","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and Hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0025-6196(11)61031-8","article-title":"Nonsurgical management of primary hyperparathyroidism","volume":"82","author":"Farford","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semdp.2013.06.008_bib47","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"2249","article-title":"Disease of the Parathyroid gland and other hyper-and hypocalcemic disorders","author":"Potts","year":"2005"},{"key":"10.1053\/j.semdp.2013.06.008_bib48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperparathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"key":"10.1053\/j.semdp.2013.06.008_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/en.133.2.617","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues","volume":"133","author":"Urena","year":"1993","journal-title":"Endocrinology"},{"issue":"suppl 1","key":"10.1053\/j.semdp.2013.06.008_bib50","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00005344-199800001-00042","article-title":"Expression of parthyroid hormone\/parathyroid hormone-related protein receptor in vascular endothelial cells","volume":"31","author":"Jiang","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.semdp.2013.06.008_bib51","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease\u2014a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","article-title":"Subacute infusion of physiological doses of parathyroid hormones raises blood pressure in humans","volume":"12","author":"Fliser","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2013.06.008_bib53","first-page":"77","article-title":"Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems","volume":"21","author":"Gennari","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/00007611-198909000-00014","article-title":"Hypomagnesemia and hypertension in primary hyperparathyroidism","volume":"82","author":"Sangal","year":"1989","journal-title":"South Med J"},{"key":"10.1053\/j.semdp.2013.06.008_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/hrt.54.5.539","article-title":"Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism\u2014an association","volume":"54","author":"Symons","year":"1985","journal-title":"Br Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jc.82.1.106","article-title":"Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up","volume":"82","author":"Stefenelli","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","article-title":"Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy","volume":"95","author":"Stefenelli","year":"1993","journal-title":"Am J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib58","first-page":"30","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"261","author":"Schluter","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj3100439","article-title":"Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phophodiesterase activity","volume":"310","author":"Schluter","year":"1995","journal-title":"Biochem J"},{"key":"10.1053\/j.semdp.2013.06.008_bib60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005344-200110000-00001","article-title":"Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart","volume":"38","author":"Shimoyama","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.semdp.2013.06.008_bib61","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1161\/01.CIR.96.10.3704","article-title":"Positive chronotropic actions of parathyroid hormone and parathyroid hormone related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential","volume":"96","author":"Hara","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jemermed.2004.06.014","article-title":"Hypocalcemic cardiac failure in the emergency department","volume":"28","author":"Hurley","year":"2005","journal-title":"J Emerg Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib63","series-title":"Cardiovascular Pathology","first-page":"493","article-title":"Cardiovascular effects of systemic diseases and conditions","author":"Lester","year":"2001"},{"key":"10.1053\/j.semdp.2013.06.008_bib64","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1053\/j.semdp.2013.06.008_bib65","first-page":"N2","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib66","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib67","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2 year study","volume":"2002","author":"Parker","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral Alendronate increases bone mineral density in post-menopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib69","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The Calcimimetic Cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib72","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib73","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"2127","article-title":"Disorders of the adrenal cortex","author":"Williams","year":"2005"},{"key":"10.1053\/j.semdp.2013.06.008_bib74","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib75","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","article-title":"Cardiovascular consequences of cortisol excess","volume":"1","author":"Whitworth","year":"2005","journal-title":"Vasc Health Risk Manag"},{"issue":"suppl 2","key":"10.1053\/j.semdp.2013.06.008_bib76","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/00004872-200406002-00162","article-title":"Vasopressin, hypertension and adrenal steroids","volume":"22","author":"Giuditta","year":"2004","journal-title":"J Hypertens"},{"key":"10.1053\/j.semdp.2013.06.008_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004872-198708000-00007","article-title":"Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man","volume":"5","author":"Connell","year":"1987","journal-title":"J Hypertens"},{"key":"10.1053\/j.semdp.2013.06.008_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-2143(96)90120-1","article-title":"Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report","volume":"128","author":"Fimognari","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib79","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/eje.0.1490549","article-title":"Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing\u2019s syndrome","volume":"149","author":"Kirilov","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semdp.2013.06.008_bib80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.jhh.1000959","article-title":"Role of erythropoietin in cortisol-induced hypertension","volume":"14","author":"Kelly","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1053\/j.semdp.2013.06.008_bib81","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ndt\/12.6.1155","article-title":"Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?","volume":"12","author":"Langenfeld","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2013.06.008_bib82","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.HYP.36.5.912","article-title":"Cortisol, and cardiovascular disease","volume":"36","author":"Whitworth","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/j.semdp.2013.06.008_bib83","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/jcem-67-2-348","article-title":"Plasma levels of atrial natriuretic hormone in Cushing\u2019s syndrome","volume":"67","author":"Yamaji","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004872-198801000-00004","article-title":"Haemodynamic, hormonal and renal effects of adrenocorticotrophic hormone in sodium-restricted man","volume":"6","author":"Connell","year":"1988","journal-title":"J Hypertens"},{"issue":"suppl","key":"10.1053\/j.semdp.2013.06.008_bib85","first-page":"S37","article-title":"Dose\u2013response relationships and mineralcorticoid activity in cortisol-induced hypertension in humans","volume":"14","author":"Williamson","year":"1996","journal-title":"J Hyertens"},{"key":"10.1053\/j.semdp.2013.06.008_bib86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0889-8529(05)70063-3","article-title":"Newer diagnostic techniques and problems in Cushing\u2019s disease","volume":"28","author":"Findling","year":"1999","journal-title":"Endocinol Metab Clin North Am"},{"key":"10.1053\/j.semdp.2013.06.008_bib87","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2002-020534","article-title":"Nighttime salivary cortisol: a useful test for the diagnosis of Cushing\u2019s syndrome","volume":"87","author":"Papanicolaou","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib88","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1210\/jc.83.8.2681","article-title":"Late-night salivary cortisol as a screening test for Cushing\u2019s syndrome","volume":"83","author":"Raff","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib89","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/jc.84.2.440","article-title":"Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.semdp.2013.06.008_bib90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/j.semdp.2013.06.008_bib91","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"2152","article-title":"Diabetes mellitus","author":"Powers","year":"2005"},{"key":"10.1053\/j.semdp.2013.06.008_bib92","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.1016\/S1098-3597(07)80019-6","article-title":"Metabolic consequences of hyperglycemia and insulin resistance","volume":"8","author":"Jellinger","year":"2007","journal-title":"Clin Cornerstone"},{"key":"10.1053\/j.semdp.2013.06.008_bib93","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0140-6736(06)69700-6","article-title":"Global and regional mortality from ischaemic heart disease and stroke attributable to higher than optimum blood glucose concentration: comparative risk assessment","volume":"368","author":"Danaei","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib94","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.100.8.820","article-title":"Insulin stimulates both endothelin and nitric oxide activity in the human forearm","volume":"100","author":"Cardillo","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib95","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bcp.2004.11.022","article-title":"Insulin-stimulation endothelial nitric oxide release in calcium independent and mediated via protein kinase B","volume":"69","author":"Hartell","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.semdp.2013.06.008_bib96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semdp.2013.06.008_bib97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2337\/diabetes.51.1.42","article-title":"Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow","volume":"51","author":"Vincent","year":"2002","journal-title":"Diabetes"},{"key":"10.1053\/j.semdp.2013.06.008_bib98","first-page":"H2160","article-title":"Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans","volume":"265","author":"Kahn","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib99","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00092.2005","article-title":"Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production dysfunction characterized by imbalance between NO and ET-1 production","volume":"289","author":"Potenza","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib100","first-page":"1161","article-title":"Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscles","volume":"92","author":"Kahn","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib101","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI115426","article-title":"Insulin attenuates vasopressin-induced calcium transients and a voltage dependent calcium response in rat vascular smooth muscle cells","volume":"88","author":"Standley","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib102","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1172\/JCI116685","article-title":"Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells","volume":"92","author":"Saito","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib103","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/CIRCULATIONAHA.104.497461","article-title":"Insulin causes Ca2+ dependent and Ca2+-independent positive inotropic effects in failing human myocardium","volume":"111","author":"von Lewinski","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib104","first-page":"2588","article-title":"Stimulation of l-type Ca2+ current in human atrial myocytes by insulin","volume":"111","author":"Maier","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0008-6363(02)00718-6","article-title":"Insulin and myocardial blood flow","volume":"57","author":"Sundell","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib106","doi-asserted-by":"crossref","first-page":"37670","DOI":"10.1074\/jbc.M204572200","article-title":"Akt signaling mediates postnatal heart growth in response to insulin and nutritional status","volume":"277","author":"Shiojima","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2013.06.008_bib107","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1172\/JCI0213946","article-title":"Insulin signaling coordinately regulates cardiac size, metabolism and contractile protein isoform expression","volume":"109","author":"Belke","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2005.12.026","article-title":"Lipid and lipoprotein dysregulation in insulin resistant states","volume":"368","author":"Ayramoglu","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.semdp.2013.06.008_bib109","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/diacare.27.9.2253","article-title":"Lipids and glucose in type 2 diabetes: what is the cause and effect?","volume":"27","author":"Boden","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semdp.2013.06.008_bib110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.283.2.221","article-title":"Hyperinsulinemia, hyperglycemia and impaired hemostasis: the Framingham offspring study","volume":"283","author":"Meigs","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semdp.2013.06.008_bib111","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI115842","article-title":"Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension","volume":"90","author":"Lembo","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib113","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/diaclin.21.4.186","article-title":"Glucose, advanced glycation end products, and diabetes complications: what is new and what works","volume":"21","author":"Peppa","year":"2003","journal-title":"Clin Diab"},{"key":"10.1053\/j.semdp.2013.06.008_bib114","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells in mice. A potential mechanism for the accelerated vasculopathy of diabetes","volume":"96","author":"Schmidt","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2013.06.008_bib115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circ Res"},{"key":"10.1053\/j.semdp.2013.06.008_bib116","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","article-title":"Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy","volume":"88","author":"Hammes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2013.06.008_bib117","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1053\/j.semdp.2013.06.008_bib118","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2013.06.008_bib119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"issue":"suppl 32","key":"10.1053\/j.semdp.2013.06.008_bib120","first-page":"s10","article-title":"Clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"1","year":"2008","journal-title":"Can J Diabetes"},{"key":"10.1053\/j.semdp.2013.06.008_bib121","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","article-title":"The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy","volume":"47","author":"Asbun","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.163.1.33","article-title":"Cardiovascular disease in type 2 diabetes mellitus","volume":"163","author":"Mooradian","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib123","first-page":"202","article-title":"Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications","volume":"25","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semdp.2013.06.008_bib124","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib126","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.314.7093.1512","article-title":"Prospective randomised study of intensive treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus","volume":"314","author":"Malmberg","year":"2008","journal-title":"Br Med J"},{"key":"10.1053\/j.semdp.2013.06.008_bib127","first-page":"2457","article-title":"Intensive insulin therapy in critically ill patients","volume":"356","author":"Van Den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib128","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib129","first-page":"2560","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"35","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib130","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of Rosiglitiazone on risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib131","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose intolerant myocardial infarction survives with average cholesterol levels: subgroup analysis in the cholesterol and recurrent events (CARE) trial","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib132","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinivian Simvastatin Survival Study (4S)","volume":"20","author":"Pyorala","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semdp.2013.06.008_bib133","first-page":"7","article-title":"Study of cholesterol lowering with simvastatin in 20,536 high-risk patients: a randomised placebo controlled trial","volume":"36","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib134","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"Turner","year":"1998","journal-title":"Br Med J"},{"key":"10.1053\/j.semdp.2013.06.008_bib135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"Br Med J"},{"key":"10.1053\/j.semdp.2013.06.008_bib136","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in patients with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib137","first-page":"320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment","volume":"296","year":"1998","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.semdp.2013.06.008_bib138","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2013.06.008_bib139","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0889-8529(18)30372-4","article-title":"Acromegaly: diagnosis and therapy","volume":"18","author":"Barkan","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.semdp.2013.06.008_bib140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of acromegaly","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"key":"10.1053\/j.semdp.2013.06.008_bib141","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinte.1938.00180100014002","article-title":"The heart in acromegaly","volume":"61","author":"Corville","year":"1938","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib142","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semdp.2013.06.008_bib143","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.CIR.93.4.800","article-title":"Differential cardiac effects of growth hormone and IGF-1 in the rat. A combined in vivo and in vitro evaluation","volume":"93","author":"Cittadini","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib144","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (oxf)"},{"key":"10.1053\/j.semdp.2013.06.008_bib145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1067\/mhj.2002.122167","article-title":"Treatment of acromegaly improves myocardial abnormalities","volume":"143","author":"Vianna","year":"2002","journal-title":"Am Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib146","first-page":"243","article-title":"Electrocardiogram in endocrine and metabolic disorders","volume":"8","author":"Surawicz","year":"1977","journal-title":"Cardiovasc Clin"},{"key":"10.1053\/j.semdp.2013.06.008_bib147","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","article-title":"Arrhythmia profile in acromegaly","volume":"13","author":"Kahaly","year":"1992","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.semdp.2013.06.008_bib148","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2003-0009","article-title":"Cardiovascular function in acromegaly","volume":"24","author":"Clayton","year":"2003","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1053\/j.semdp.2013.06.008_bib149","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2001.01256.x","article-title":"Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1053\/j.semdp.2013.06.008_bib150","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jc.87.7.3174","article-title":"Early vascular alterations in acromegaly","volume":"87","author":"Brevetti","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semdp.2013.06.008_bib151","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1053\/j.semdp.2013.06.008_bib152","first-page":"29","article-title":"Canadian consensus guidelines for the diagnosis and management of acromegaly","volume":"29","author":"Ezzat","year":"2006","journal-title":"Clin Invest Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib153","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","article-title":"Signaling pathways for cardiac hypertrophy and failure","volume":"341","author":"Hunter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib154","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.7326\/0003-4819-34-6-1445","article-title":"Acromegaly and the heart: a clinical and pathologic study","volume":"34","author":"Hejtmancik","year":"1951","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semdp.2013.06.008_bib155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-X","article-title":"Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients","volume":"100","author":"Lie","year":"1980","journal-title":"Am Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib156","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nrendo.2009.175","article-title":"Somatostatin analog and pegvsiomant combination therapy for acromegaly","volume":"5","author":"Sebastien","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1053\/j.semdp.2013.06.008_bib157","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development and use in patients with acromegaly","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semdp.2013.06.008_bib158","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","article-title":"An analysis of 8305 cases of carcinoid tumors","volume":"79","author":"Modlin","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2013.06.008_bib159","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib160","first-page":"440","article-title":"Ein Fall von Angioma teleangieactaticium Cutis mit chronischer Endocarditis und malignem Dunndarmascarcinoid","volume":"86","author":"Scholte","year":"1931","journal-title":"Beitragpath Anat"},{"issue":"2","key":"10.1053\/j.semdp.2013.06.008_bib161","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid heart disease: relationship of circulating vasoactive substance to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"key":"10.1053\/j.semdp.2013.06.008_bib162","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease","volume":"129","author":"Gustafsson","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semdp.2013.06.008_bib163","first-page":"71","article-title":"Involvement of transforming growth factor in the formation of fibrotic lesions in carcinoid heart disease","volume":"142","author":"Waltenberger","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2013.06.008_bib164","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.semdp.2013.06.008_bib165","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SMJ.0b013e3181b67356","article-title":"Carcinoid tumors of the gastrointestinal tract","volume":"102","author":"Ghevariya","year":"2009","journal-title":"South Med J"},{"key":"10.1053\/j.semdp.2013.06.008_bib166","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clinchem\/32.5.840","article-title":"Urinary serotonin in the diagnosis of carcinoid tumors","volume":"32","author":"Feldman","year":"1986","journal-title":"Clin Chem"},{"key":"10.1053\/j.semdp.2013.06.008_bib167","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/pgmj.71.839.542","article-title":"The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid","volume":"71","author":"Tormey","year":"1995","journal-title":"Postgrad Med J"},{"issue":"7","key":"10.1053\/j.semdp.2013.06.008_bib168","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008215730767","article-title":"Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center","volume":"8","author":"Janson","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2013.06.008_bib169","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1749-6632.1994.tb17300.x","article-title":"Radiotherapy with a radiolabeled somatostatin analogue [111-In-DTPA-d-Phe1]-octreotide. A case history","volume":"733","author":"Krenning","year":"1994","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1053\/j.semdp.2013.06.008_bib170","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2013.06.008_bib171","doi-asserted-by":"crossref","first-page":"1129.e1","DOI":"10.1016\/j.ahj.2006.02.019","article-title":"Assessment of patent foramen ovale in carcinoid heart disease","volume":"151","author":"Mansencal","year":"2006","journal-title":"Am Heart J"},{"key":"10.1053\/j.semdp.2013.06.008_bib172","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0046-8177(76)80054-8","article-title":"The carcinoid endocardial plaque: an ultrastructural study","volume":"7","author":"Ferrans","year":"1976","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2013.06.008_bib173","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","article-title":"Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years","volume":"77","author":"Simula","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semdp.2013.06.008_bib174","first-page":"115","article-title":"Balloon dilation of tricuspid and pulmonary valves in carcinoid heart disease","volume":"20","author":"Onate","year":"1993","journal-title":"Texas Heart Inst J"},{"key":"10.1053\/j.semdp.2013.06.008_bib175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0167-5273(94)90274-7","article-title":"Successful balloon dilatation of the pulmonary valve in carcinoid heart disease","volume":"45","author":"Hargreaves","year":"1994","journal-title":"Int J Cardiol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257013000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257013000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T05:32:12Z","timestamp":1596691932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257013000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0740257013000233"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2013.06.008","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}